Catalog Products » HLA-A*02:03&B2M&AFP (FMNKFIYEI) Tetramer, His & Avi, Human
Manual
Manual
COAs

HLA-A*02:03&B2M&AFP (FMNKFIYEI) Tetramer, His & Avi, Human

Alpha-fetoprotein (AFP), a specific liver cancer marker, T cells expressing AFP-CAR selectively degranulated, released cytokines, and lysed liver cancer cells that were HLA-A*02:01 /AFP while sparing cells from multiple tissue types that were negative for either expressed proteins.CAR T-cell immunotherapy targeting intracellular/secreted solid tumor antigens can elicit a potent antitumor response.
$1120.00
Z06601-100

Ask us a question
Product Introduction
Species Human
Protein Construction
HLA-A*02:03&B2M&AFP (FMNKFIYEI) Tetramer[Gly25-Thr305(HLA-A*02:03), Ile21-Met119(B2M) and FMNKFIYEI peptide]
Accession # AAA03604.1(HLA-A*02:03)&P61769(B2M)&FMNKFIYEI		 His Avi
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE
Endotoxin Level Less than 1EU per μg by the LAL method.
Expression System HEK293
Theoretical Molecular Weight 258 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 260-265 kDa under Non reducing (N) condition based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.
Back

HLA-A*02:03&B2M&AFP (FMNKFIYEI) Tetramer, His & Avi, Human

The purity of HLA-A*02:03&B2M&AFP (FMNKFIYEI) Tetramer, His & Avi, Human is greater than 95% as determined by SEC-HPLC. »

HLA-A*02:03&B2M&AFP (FMNKFIYEI) Tetramer, His & Avi, Human

HLA-A*02:03&B2M&AFP (FMNKFIYEI) Tetramer, His & Avi, Human on Bis-Tris PAGE under Non reduced (N) condition. The purity is greater than 95%. »

<
>

Background
Target Background Alpha-fetoprotein (AFP), a specific liver cancer marker, T cells expressing AFP-CAR selectively degranulated, released cytokines, and lysed liver cancer cells that were HLA-A*02:01 /AFP while sparing cells from multiple tissue types that were negative for either expressed proteins.CAR T-cell immunotherapy targeting intracellular/secreted solid tumor antigens can elicit a potent antitumor response.
Synonyms Alpha-fetoprotein; Alpha-1-fetoprotein; Alpha-feto; AFP; HPAFP; AFPD; FETA; MHC
Back

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.